ImmuCell Corp (ICCC.OQ)

ICCC.OQ on NASDAQ Stock Exchange Capital Market

21 Nov 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


ImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle,... (more)
No analyst recommendations are available for .


Beta: 1.12
Market Cap(Mil.): $35.34
Shares Outstanding(Mil.): 5.05
Dividend: --
Yield (%): --


BRIEF-Immucell Q3 loss per share $0.07

* Immucell announces financial results for third quarter of 2017

14 Nov 2017

BRIEF-ImmuCell announces expansion of sales and marketing team

* ImmuCell Corp - ‍during Q4 of 2017, company expects to achieve regulatory approval of First Defense Tri-Shield​

13 Sep 2017

BRIEF-ImmuCell Q2 loss per share $0.05

* ImmuCell announces financial results for second quarter of 2017

15 Aug 2017

BRIEF-Immucell enters into amendment to agreement with Plas-Pak Industries

* On July 24, co entered into amendment to agreement with Plas-Pak Industries of Norwich, Connecticut, originally dated as of January 4, 2010

25 Jul 2017


  Price Chg
Merck & Co., Inc. (MRK.N) $54.27 +0.17
Pfizer Inc. (PFE.N) $35.54 +0.19
Eli Lilly and Co (LLY.N) $83.51 +0.33

Earnings vs. Estimates

No consensus analysis data available.